<< Read Full Article

Dendreon's Date With Destiny

Stock quotes in this article: DNDN , CYBX , ABT  

Updated from March 8

Dendreon(DNDN Quote) will take its prostate cancer drug Provenge in front of an FDA advisory panel on March 29. This is going to be a major stock-moving event, and for me, at least, the outcome is very much in the air.

I said as much in a column last week, but I also promised to dig deeper into the story. Having done so, here's a discussion of the issues surrounding Provenge's date with the FDA.

What is Provenge? ...

<< Read Full Article

Recent Comments

Loading .....




Dow Jones S&P 500 NASDAQ 10-Year Note
10,479.66 1,110.06 2,179.06 32.55
Oil *
79.45
UP
134.82
UP
14.43
UP
34.46
UP
0.54
10 Yr
3.25%
SPDR Gold
117.44
+1.30%
+1.32%
+1.61%
+1.69%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services